Clinical Trial Update: Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating tirelizumab in combination with chemoradiation for unresectable locally advanced gastric cancer or gastroesophageal junctio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Tirelizumab (tirelizumab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Locally Advanced Gastric Cancer | Phase 2 | Status: UNKNOWN